GLP-1 medications have changed the game for weight loss, but not everyone sees the same results
It may also reduce the risk of major cardiovascular events such as heart attack and stroke in people with type 2 diabetes and established cardiovascular disease
This makes it a favorite among performance athletes, anti-aging enthusiasts, and individuals looking to improve recovery, fat loss, and lean muscle gain through natural hormonal optimization
Measurement burden GH-axis options may add IGF-1 and glucose questions
Mounjaro, on the other hand, is a GLP-1/GIP agonist, meaning that in addition to acting as GLP-1 in the body, it also mimics the glucose-dependent insulinotropic polypeptide (GIP), sometimes known as the gastric inhibitory polypeptide, that, like GLP-1, triggers insulin secretion
Source: Business Insider Africa